Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2024

BUY
$191.51 - $216.16 $489 Million - $552 Million
2,554,682 New
2,554,682 $542 Million
Q3 2023

Nov 13, 2023

SELL
$191.51 - $216.16 $364 Million - $411 Million
-1,899,159 Closed
0 $0
Q2 2023

Aug 14, 2024

BUY
$187.64 - $206.25 $508 Million - $558 Million
2,707,019 New
2,707,019 $521 Million
Q2 2023

Aug 14, 2023

SELL
$187.64 - $206.25 $322 Million - $353 Million
-1,713,639 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$127.59 - $203.08 $255 Million - $405 Million
1,996,522 New
1,996,522 $404 Million
Q4 2022

Feb 14, 2023

BUY
$117.37 - $139.17 $257 Million - $304 Million
2,187,105 New
2,187,105 $281 Million
Q3 2022

Nov 13, 2023

BUY
$135.27 - $180.11 $257 Million - $342 Million
1,899,159 New
1,899,159 $260 Million
Q2 2022

Aug 14, 2023

BUY
$108.81 - $179.33 $186 Million - $307 Million
1,713,639 New
1,713,639 $303 Million
Q1 2022

May 12, 2023

SELL
$119.61 - $157.85 $35.7 Million - $47.1 Million
-298,459 Reduced 13.65%
1,888,646 $272 Million
Q1 2022

May 09, 2022

SELL
$119.61 - $157.85 $208 Million - $274 Million
-1,735,414 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$142.57 - $190.86 $247 Million - $331 Million
1,735,414 New
1,735,414 $268 Million
Q3 2021

Nov 14, 2022

BUY
$142.45 - $169.82 $222 Million - $264 Million
1,555,290 New
1,555,290 $264 Million
Q3 2021

Nov 05, 2021

SELL
$142.45 - $169.82 $201 Million - $239 Million
-1,409,376 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$135.08 - $161.1 $190 Million - $227 Million
1,409,376 New
1,409,376 $223 Million
Q2 2021

Aug 10, 2021

SELL
$135.08 - $161.1 $192 Million - $228 Million
-1,417,890 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$137.51 - $190.8 $195 Million - $271 Million
1,417,890 New
1,417,890 $197 Million
Q1 2021

May 07, 2021

SELL
$137.51 - $190.8 $181 Million - $252 Million
-1,319,525 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$164.63 - $211.93 $217 Million - $280 Million
1,319,525 New
1,319,525 $231 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.